<DOC>
	<DOCNO>NCT00981448</DOCNO>
	<brief_summary>The purpose study evaluate effect zinc supplementation insulin secretion genotype SLC30A8 .</brief_summary>
	<brief_title>Nutrigenomics Zinc Supplementation Insulin Secretion Diabetes</brief_title>
	<detailed_description>As diabetes increase alarm rate , strategies prevention disease must develop . For give individual , biologic ( e.g. , genetic ) environmental ( e.g. , lifestyle ) factor comprise individual risk diabetes . Researchers take advantage accumulate knowledge individual factor design individualized strategy diabetes risk assessment prevention . For example , mutation particular gene , SLC30A8 , encode zinc transporter , show increase risk diabetes probably impairment insulin secretion . In proposed research project , investigator aim conduct pilot study see effect zinc supplementation insulin secretion people without genetic mutation see zinc improve insulin secretion mutation . The result study help investigator plan large , definitive study determine zinc supplementation use prevent treat diabetes mutation SLC30A8 .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>age 2170 year Amish decent genotyping rs13266634 SLC30A8 gene previously consent contact future study future use DNA Subject firstdegree relative another subject SLC30A8 genotype diabetes mellitus ( history , treatment random BG &gt; 200 mg ; dl ) gastrointestinal disease cause nausea , vomit , diarrhea include inflammatory bowel disease history . rheumatoid arthritis history albumin &lt; 3.5 g/dL hemochromatosis history hematocrit &lt; 34 % liver disease history alanine aminotransferase aspartate aminotransferase great 2.5 time normal renal failure history estimate glomerular filtration rate &lt; 60 mL/min MDRD equation use thiazide diuretic unwilling discontinue deem safe opinion treat physician study physician 1 week prior protocol initiation use systemic corticosteroid unwilling discontinue deem safe opinion treat physician study physician 1 week prior protocol initiation use highlyactive antiretroviral medication use antipsychotic medication use quinolone antibiotic use tetracycline antibiotic unwilling discontinue deem safe opinion treat physician study physician 1 week prior protocol initiation use chelation therapy past month unwilling withdraw supplement 1 week prior study throughout study abnormal thyroid stimulate hormone ( TSH ) level serious disease preclude participation report pregnancy positive urine hCG test cancer diagnosis past 2 year breastfeed use denture adhesive</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>zinc</keyword>
	<keyword>diabetes</keyword>
	<keyword>genetics</keyword>
</DOC>